Cardiovascular risk profile in kidney transplant recipients with well controlled hypertension

被引:0
作者
Soriguer, FJ [1 ]
Lillo, JA [1 ]
Tinahones, FJ [1 ]
Gonzalez-Molina, M [1 ]
Cabello, M [1 ]
Burgos, D [1 ]
de Antonio, IE [1 ]
Garcia-Arnes, J [1 ]
Garriga, MJ [1 ]
Olveira, G [1 ]
Pareja, A [1 ]
机构
[1] Hosp Reg Carlos Haya, Secc Endocrinol, Serv Nefrol, Malaga, Spain
关键词
hypertension; kidney transplantation; lipoproteins; syndrome X;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Aim: To study the alterations of carbohydrate and lipid metabolism in a group of renal-transplant recipients. Methods and Results: A case-control study was carried out on 44 renal-transplant recipients with normal kidney function and oral glucose tolerance, and a control group of 37 healthy subjects. The following variables were studied: a) anthropometric and clinical, b) diet, c) composition of the adipose tissue fatty acids d) glycemia, insulin, and C peptide at baseline and after oral glucose tolerance rest (OGTT), e) cholesterol, triglycerides, and Apo B in total plasma and in high density lipoprotein (HDL), very low density lipoprotein (VLDL), intermediate density lipoprotein (IDL), and low density lipoprotein (LDL) separated by ultracentrifugation, Apo A-I, Apo CII, and Apo CIII in plasma. The renal-transplant recipients had a greater waist to hip ratio (0.89+/-0.09 vs 0.69+/-0.07, p=0.0008) compared to controls. Calorie intake was similar but the transplant recipients had a lower intake of saturated fat per day (31.4+/-9.6 vs 37.4+/-10.98 g/day, p=0.05). The composition of fatty acids in adipose tissue was the same in cases and controls, except for a greater proportion of lauric acid in the transplant recipients (p=0.05). The transplant recipients had significantly higher levels of cholesterol, triglycerides, and Apo B both in plasma and in VLDL, LDL, and IDL. The Apo A-I, Apo CII, and Apo CIII were significantly raised in the transplant recipients, but the Apo CII/Apo CIII ratio was significantly reduced (p=0.005). The HDL levels were similar in the transplant recipients and controls except for the HDL triglycerides, which were significantly higher (p=0.0002). Insulin values in serum were higher in the transplant recipients over the whole glucose curve with statistically significant differences at minute 90 of the curve (p=0.05). C peptide was higher in the transplant recipients at baseline (3.83+/-5.31 ng/ml VS 1.70+/-0.61 ng/ml, p=0.0001) and at minute 180 of the curve (p=0.03). The C peptide/insulin ratio was also significantly raised at these same times. Transplant recipients with hypertension had higher levels of blood glucose at minutes 30 (p=0.04) and 90 (p=0.01) of the curve, as well as a larger area under the glucose curve (p=0.03). They also had significantly higher levels of insulin at minute 90 (p=0.03), total Apo B (p=0.05), Apo B in LDL (p=0.03) and LDL-cholesterol (p=0.05). Conclusions: The rise in cholesterol and plasma triglycerides, rite apolipoprotein distribution pattern, the redistribution of the body fat, the changes in carbohydrate and insulin metabolism, are all the expression in renal-transplant recipients of a plurimetabolic syndrome, probably secondary to the simultaneous action of steroids, cyclosporine and hypotensive agents. (C) 1998, Medikal Press.
引用
收藏
页码:107 / 116
页数:10
相关论文
共 37 条
  • [1] [Anonymous], WHO TECHN REP SER
  • [2] ELEVATED SERUM-INSULIN LEVELS IN PATIENTS WITH ESSENTIAL-HYPERTENSION AND MICROALBUMINURIA
    BIANCHI, S
    BIGAZZI, R
    VALTRIANI, C
    CHIAPPONI, I
    SGHERRI, G
    BALDARI, G
    NATALI, A
    FERRANNINI, E
    CAMPESE, VM
    [J]. HYPERTENSION, 1994, 23 (06) : 681 - 687
  • [3] THE PREVALENCE OF HYPERLIPIDEMIA IN RENAL-TRANSPLANT RECIPIENTS - ASSOCIATIONS WITH IMMUNOSUPPRESSIVE AND ANTIHYPERTENSIVE THERAPY
    BITTAR, AE
    RATCLIFFE, PJ
    RICHARDSON, AJ
    RAINE, AEG
    JONES, L
    YUDKIN, PL
    CARTER, R
    MANN, JI
    MORRIS, PJ
    [J]. TRANSPLANTATION, 1990, 50 (06) : 987 - 992
  • [4] BRUNNER FP, 1988, NEPHROL DIAL TRANSPL, V2, P109
  • [5] LIPOPROTEIN-APOLIPOPROTEIN CHANGES IN RENAL-TRANSPLANT RECIPIENTS - A 2-YEAR FOLLOW-UP
    CASSADER, M
    RUIU, G
    GAMBINO, R
    ALEMANNO, N
    TRIOLO, G
    PAGANO, G
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1991, 40 (09): : 922 - 925
  • [6] CSORIGUER FS, 1992, NUTR HOSPITALARIS, V12, P33
  • [7] DECREASED POSTHEPARIN LIPOLYTIC-ACTIVITY IN RENAL-TRANSPLANT RECIPIENTS WITH CYCLOSPORINE-A
    DERFLER, K
    HAYDE, M
    HEINZ, G
    HIRSCHL, MM
    STEGER, G
    HAUSER, AC
    BALCKE, P
    WIDHALM, K
    [J]. KIDNEY INTERNATIONAL, 1991, 40 (04) : 720 - 727
  • [8] HYPERLIPIDEMIA IN STABLE RENAL-TRANSPLANT RECIPIENTS
    DIVAKAR, D
    BAILEY, RR
    FRAMPTON, CM
    GEORGE, PM
    WALMSLEY, TA
    MURPHY, J
    [J]. NEPHRON, 1991, 59 (03): : 423 - 428
  • [9] INSULIN RESISTANCE AND INSULIN DEFICIENCY IN THE PATHOGENESIS OF POSTTRANSPLANTATION DIABETES IN MAN
    EKSTRAND, AV
    ERIKSSON, JG
    GRONHAGENRISKA, C
    AHONEN, PJ
    GROOP, LC
    [J]. TRANSPLANTATION, 1992, 53 (03) : 563 - 568
  • [10] FERRANNINI E, 1990, J HYPERTENS, V8, pS169